T42. HIGH ADHERENCE TO CURRENT ANTIPSYCHOTIC AND ADJUNCTIVE PIMAVANSERIN IN THE ENHANCE STUDY, A PHASE 3 TRIAL TO EVALUATE THE TREATMENT OF SCHIZOPHRENIA IN PATIENTS WITH AN INADEQUATE RESPONSE TO ANTIPSYCHOTIC TREATMENT

BACKGROUND: Individuals with schizophrenia experience an inadequate response to antipsychotic (AP) treatment at a high rate, up to 70% in some cases (McEvoy et al. 2006). Possible reasons for this include subtherapeutic AP blood levels and medication ineffectiveness. Although patient self-report and...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbs, Brandon, Bugarski-Kirola, Dragana, (Cathy) Liu, I-Yuan, Darwish, Mona, Stankovic, Srdjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Session III
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234071/
http://dx.doi.org/10.1093/schbul/sbaa029.602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234071/
http://dx.doi.org/10.1093/schbul/sbaa029.602

Ejemplares similares